Passive immunotherapy of Bacillus anthracis pulmonary infection in mice with antisera produced by DNA immunization

Vaccine

Volumn 24, Issue 31-32, 2006, Pages 5872-5880

  Herrmann, John E ^a   Wang, Shixia ^b   Zhang, Chuanyou ^a   Panchal, Rekha G ^c   Bavari, Sina ^d   Lyons, C Rick ^e   Lovchik, Julie A ^e   Golding, Basil ^f   Shiloach, Joseph ^g   Lu, Shan ^a  

^a Antibody Science Inc   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c SAIC Frederick Inc   (United States)

^d UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^e UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^f CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^g NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

DNA vaccine; Immunotherapy; Passive immunity; Protective antibodies

Indexed keywords

ANTHRAX TOXIN; ANTHRAX VACCINE; ANTISERUM; BACTERIAL ANTIGEN; DNA VACCINE; HYPERIMMUNE GLOBULIN; IMMUNOGLOBULIN F(AB')2 FRAGMENT; IMMUNOGLOBULIN G; PLASMID DNA; PROTECTIVE ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTHRAX; ANTIGEN ANTIBODY COMPLEX; ANTIGEN PURIFICATION; ARTICLE; BACILLUS ANTHRACIS; BACTERIAL SPORE; BACTERIAL STRAIN; CODON; CONTROLLED STUDY; CYTOTOXICITY; DNA IMMUNIZATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; LD 50; LUNG INFECTION; MACROPHAGE; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; PROVOCATION TEST; RABBIT; VACCINATION;

ANIMALS; ANTHRAX; ANTHRAX VACCINES; BACILLUS ANTHRACIS; FEMALE; IMMUNE SERA; IMMUNIZATION, PASSIVE; MICE; MICE, INBRED DBA; PNEUMONIA, BACTERIAL; RABBITS; VACCINES, DNA;

EID: 33745369937     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.04.065     Document Type: Article

References (34)

1. Lane H.C., and Fauci A.S. Bioterrorism on the home front: a new challenge for American medicine. J Am Med Assn 286 20 (2001) 2595-2597
2. Lane H.C., Montagne J.L., and Fauci A.S. Bioterrorism: a clear and present danger. Nat Med 7 12 (2001) 1271-1273
3. Burnett J.C., Henchal E.A., Schmaljohn A.L., and Bavari S. The evolving field of biodefence: therapeutic developments and diagnostics. Nat Rev Drug Discov 4 4 (2005) 281-296
4. Casadevall A. Passive antibody administration (immediate immunity) as a specific defense against biological weapons. Emerg Infect Dis 8 8 (2002) 833-841
5. Enserink M. Anthrax. 'Borrowed immunity' may save future victims. Science 295 5556 (2002) 777
6. Beedham R.J., Turnbull P.C., and Williamson E.D. Passive transfer of protection against Bacillus anthracis infection in a murine model. Vaccine 19 31 (2001) 4409-4416
7. Little S.F., Ivins B.E., Fellows P.F., and Friedlander A.M. Passive protection by polyclonal antibodies against Bacillus anthracis infection in guinea pigs. Infect Immun 65 12 (1997) 5171-5175
8. Kobiler D., Gozes Y., Rosenberg H., Marcus D., Reuveny S., and Altboum Z. Efficiency of protection of guinea pigs against infection with Bacillus anthracis spores by passive immunization. Infect Immun 70 2 (2002) 544-560
9. Galloway D., Liner A., Legutki J., Mateczun A., Barnewall R., and Estep J. Genetic immunization against anthrax. Vaccine 22 13-14 (2004) 1604-1608
10. Price B.M., Liner A.L., Park S., Leppla S.H., Mateczun A., and Galloway D.R. Protection against anthrax lethal toxin challenge by genetic immunization with a plasmid encoding the lethal factor protein. Infect Immun 69 7 (2001) 4509-4515
11. Gu M.L., Leppla S.H., and Klinman D.M. Protection against anthrax toxin by vaccination with a DNA plasmid encoding anthrax protective antigen. Vaccine 17 4 (1999) 340-344
12. Riemenschneider J., Garrison A., Geisbert J., Jahrling P., Hevey M., Negley D., et al. Comparison of individual and combination DNA vaccines for B. anthracis, Ebola virus, Marburg virus and Venezuelan equine encephalitis virus. Vaccine 21 25-26 (2003) 4071-4080
13. Williamson E.D., Beedham R.J., Bennett A.M., Perkins S.D., Miller J., and Baillie L.W. Presentation of protective antigen to the mouse immune system: immune sequelae. J Appl Microbiol 87 2 (1999) 315-317
14. Wang S., Heilman, Liu F., Chou T.-H., Giehl T., Joshi S., et al. A DNA vaccine producing LcrV antigen in oligomers is as effective as protein-based vaccines in protecting mice from pneumonic plague. Vaccine 22 25-26 (2004) 3348-3357
15. Ulmer J.B., Deck R.R., DeWitt C.M., Friedman A., Donnelly J.J., and Liu M.A. Protective immunity by intramuscular injection of low doses of influenza virus DNA vaccines. Vaccine 12 16 (1994) 1541-1544
16. Lodmell D.L., Ray N.B., Parnell M.J., Ewalt L.C., Hanlon C.A., Shaddock J.H., et al. DNA immunization protects nonhuman primates against rabies virus. Nat Med 4 8 (1998) 949-952
17. Xu L., Sanchez A., Yang Z., Zaki S.R., Nabel E.G., Nichol S.T., et al. Immunization for Ebola virus infection. Nat Med 4 1 (1998) 37-42
18. Yang Z.Y., Kong W.P., Huang Y., Roberts A., Murphy B.R., Subbarao K., et al. A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice. Nature 428 6982 (2004) 561-564
19. Lu S., Arthos J., Montefiori D.C., Yasutomi Y., Manson K., Mustafa F., et al. Simian immunodeficiency virus DNA vaccine trial in macaques. J Virol 70 6 (1996) 3978-3991
20. Lu S., Manning S., and Arthos J. Antigen engineering in DNA immunization. In: Lowrie D., and Walen R. (Eds). Methods in molecular medicine 29 (1998) 355-374
21. Wang S., Joshi S., and Lu S. Delivery of DNA to skin by particle bombardment (2003), Humana Press Inc., Totowa, NJ p. 185-96
22. Pitt M.L., Little S.F., Ivins B.E., Fellows P., Barth J., Hewetson J., et al. In vitro correlate of immunity in a rabbit model of inhalational anthrax. Vaccine 19 32 (2001) 4768-4773
23. Wang S., Chou T.H., Sakhatskyy P.V., Huang S., Lawrence J.M., Cao H., et al. Identification of two neutralizing regions on the severe acute respiratory syndrome coronavirus spike glycoprotein produced from the mammalian expression system. J Virol 79 3 (2005) 1906-1910
24. Welkos S., Little S., Friedlander A., Fritz D., and Fellows P. The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores. Microbiology 147 Pt 6 (2001) 1677-1685
25. Lyons C.R., Lovchik J., Hutt J., Lipscomb M.F., Wang E., Heninger S., et al. Murine model of pulmonary anthrax: kinetics of dissemination, histopathology, and mouse strain susceptibility. Infect Immun 72 8 (2004) 4801-4809
26. Maynard J.A., Maassen C.B., Leppla S.H., Brasky K., Patterson J.L., Iverson B.L., et al. Protection against anthrax toxin by recombinant antibody fragments correlates with antigen affinity. Nat Biotechnol 20 6 (2002) 597-601
27. Zhao P., Liang X., Kalbfleisch J., Koo H.M., and Cao B. Neutralizing monoclonal antibody against anthrax lethal factor inhibits intoxication in a mouse model. Hum Antibodies 12 4 (2003) 129-135
28. Sawada-Hirai R., Jiang I., Wang F., Sun S.M., Nedellec R., Ruther P., et al. Human anti-anthrax protective antigen neutralizing monoclonal antibodies derived from donors vaccinated with anthrax vaccine adsorbed. J Immune Based Ther Vaccines 2 1 (2004) 5
29. Casadevall A. Antibody-based defense strategies against biological weapons. Am Soc Microbiol News 71 (2005) 28-32
30. Karginov V.A., Robinson T.M., Riemenschneider J., Golding B., Kennedy M., Shiloach J., et al. Treatment of anthrax infection with combination of ciprofloxacin and antibodies to protective antigen of Bacillus anthracis. FEMS Immunol Med Microbiol 40 1 (2004) 71-74
31. Smith T.W., Butler Jr. V.P., Haber E., Fozzard H., Marcus F.I., Bremner W.F., et al. Treatment of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments: experience in 26 cases. N Engl J Med 307 22 (1982) 1357-1362
32. 2 heptavalent botulism immune globulin of equine origin during an outbreak of type E botulism in Egypt. Clin Infect Dis 23 2 (1996) 337-340
33. Bush S.P., Green S.M., Moynihan J.A., Hayes W.K., and Cardwell M.D. Crotalidae polyvalent immune Fab (ovine) antivenom is efficacious for envenomations by Southern Pacific rattlesnakes (Crotalus helleri). Ann Emerg Med 40 6 (2002) 619-624
34. Ramshaw I.A., and Ramsay A.J. The prime-boost strategy: exciting prospects for improved vaccination. Immunol Today 21 4 (2000) 163-165